772196006: Abacavir + Lamivudine + Dolutegravir (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Abacavir + Lamivudine + Dolutegravir

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing nucleotidyltransferase inhibitor\Product containing integrase strand transfer inhibitor\Product containing dolutegravir\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing reverse transcriptase inhibitor\Product containing abacavir\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing reverse transcriptase inhibitor\Product containing lamivudine\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing reverse transcriptase inhibitor\Product containing lamivudine\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrimidine\Product containing lamivudine\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrimidine\Product containing lamivudine\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing dolutegravir\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by structure\Product containing nucleoside analog\Product containing abacavir\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by structure\Product containing nucleoside analog\Product containing lamivudine\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by structure\Product containing nucleoside analog\Product containing lamivudine\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing dolutegravir\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing abacavir\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing lamivudine\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing lamivudine\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3717593011 Abacavir and dolutegravir and lamivudine only product en Synonym Active Entire term case insensitive SNOMED CT core module

3717594017 Product containing only abacavir and dolutegravir and lamivudine (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module

2871951000001115 Abacavir + Lamivudine + Dolutegravir (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom Edition module

2871961000001117 Abacavir + Lamivudine + Dolutegravir en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Abacavir + Lamivudine + Dolutegravir	Has active ingredient	Lamivudine	true	Inferred relationship	Existential restriction modifier	1
Abacavir + Lamivudine + Dolutegravir	Has active ingredient	Dolutegravir	true	Inferred relationship	Existential restriction modifier	3
Abacavir + Lamivudine + Dolutegravir	Has active ingredient	Abacavir	true	Inferred relationship	Existential restriction modifier	2
Abacavir + Lamivudine + Dolutegravir	Count of base of active ingredient	3	false	Inferred relationship	Existential restriction modifier
Abacavir + Lamivudine + Dolutegravir	Is a	Product containing abacavir and dolutegravir and lamivudine	true	Inferred relationship	Existential restriction modifier
Abacavir + Lamivudine + Dolutegravir	Plays role	Antiretroviral therapeutic role	true	Inferred relationship	Existential restriction modifier
Abacavir + Lamivudine + Dolutegravir	Is a	Virtual therapeutic moiety	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing only abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form)	Is a	True	Abacavir + Lamivudine + Dolutegravir	Inferred relationship	Existential restriction modifier
Generic Triumeq 50mg/600mg/300mg tablets	Is a	True	Abacavir + Lamivudine + Dolutegravir	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3717593011	Abacavir and dolutegravir and lamivudine only product	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3717594017	Product containing only abacavir and dolutegravir and lamivudine (medicinal product)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
2871951000001115	Abacavir + Lamivudine + Dolutegravir (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom Edition module
2871961000001117	Abacavir + Lamivudine + Dolutegravir	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom Edition module